What is the ACE2 receptor, how is it connected to coronavirus and why might it be key to treating COVID-19? The experts explain
Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19 | Critical Care | Full Text
SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy
Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers in COVID-19 - The Centre for Evidence-Based Medicine
Frontiers | Combination of Angiotensin (1-7) Agonists and Convalescent Plasma as a New Strategy to Overcome Angiotensin Converting Enzyme 2 (ACE2) Inhibition for the Treatment of COVID-19
Cureus | A Rare Case of Dose-Dependent Losartan-Induced Angioedema | Article
Coronavirus disease 2019 (COVID-19) and the renin-angiotensin system: A closer look at angiotensin-converting enzyme 2 (ACE2) - Annalise E Zemlin, Owen J Wiese, 2020
Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers in COVID-19 - The Centre for Evidence-Based Medicine
Angiotensin-converting enzyme 2 and angiotensin 1–7: novel therapeutic targets | Nature Reviews Cardiology
Selective Inhibition of the C-Domain of ACE (Angiotensin-Converting Enzyme) Combined With Inhibition of NEP (Neprilysin): A Potential New Therapy for Hypertension | Hypertension
Angiotensin and the Coronavirus | Science | AAAS
SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy - eBioMedicine
Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB | SpringerLink
Frontiers | Regulated Intramembrane Proteolysis of ACE2: A Potential Mechanism Contributing to COVID-19 Pathogenesis?
The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19: Molecular Therapy - Methods & Clinical Development
View of The regulation of ACE-2 in the heart and lungs | The Southwest Respiratory and Critical Care Chronicles
Angiotensin-Converting Enzyme II in the Heart and the Kidney | Circulation Research
Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target | SpringerLink
ACE2 as a potential therapeutic target for pandemic COVID-19 - RSC Advances (RSC Publishing) DOI:10.1039/D0RA08228G
Quercetin and Its Metabolites Inhibit Recombinant Human Angiotensin-Converting Enzyme 2 (ACE2) Activity | Journal of Agricultural and Food Chemistry
Angiotensin Converting Enzyme (ACE) inhibitors: Mechanism of Action and Clinical Findings | Calgary Guide
Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors—lessons from available evidence and insights into COVID-19 | Hypertension Research
SARS-CoV-2 receptor ACE2-dependent implications on the cardiovascular system: From basic science to clinical implications - ScienceDirect
Role of angiotensin-converting enzyme 2 in neurodegenerative diseases during the COVID-19 pandemic | Aging
Frontiers | Role of Renin-Angiotensin System Components in Atherosclerosis: Focus on Ang-II, ACE2, and Ang-1–7
SARS-CoV-2 Infection & Cardiology: Overview on Renin-Angiotensin-Aldosterone System Inhibition
